Venugopal Gudipati

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Hannes Stockinger

University Professor

Medical University of Vienna

AUSTRIA

View details

Al Nasar Ahmed Sehgal

Medical University of Vienna

AUSTRIA

View details

Winfried Wels

GERMANY

View details

Ursula Wiedermann

Medical University of Vienna

AUSTRIA

View details

Johannes Huppa

Professor

Medical University of Vienna

AUSTRIA

View details

Elisabeth Simader

Medical University of Vienna

AUSTRIA

View details

Daniel Mrak

Medical University of Vienna

AUSTRIA

View details

Michael Bonelli

Medical University of Vienna

AUSTRIA

View details

Dieter Beule

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Marianne Graninger

Medical University of Vienna

AUSTRIA

View details

Renate Kunert

Univ. Prof.

University of Natural Resources and Life Sciences

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Venugopal Gudipati

Research Interests

Explore related searches

Contact this professor

Articles (10)

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation

The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects.

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year

Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responses

Inefficient CAR-proximal signaling blunts antigen sensitivity

Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells

Collaborators (11)

Hannes Stockinger

Al Nasar Ahmed Sehgal

Winfried Wels

Ursula Wiedermann

Johannes Huppa

Elisabeth Simader

Daniel Mrak

Michael Bonelli

Dieter Beule

Marianne Graninger

Renate Kunert

Make your next move.